Non-coding RNAs in Wilms' tumor: biological function, mechanism, and clinical implications

J Mol Med (Berl). 2021 Aug;99(8):1043-1055. doi: 10.1007/s00109-021-02075-1. Epub 2021 May 5.

Abstract

Non-coding RNAs are involved with maintenance and regulation of physiological mechanisms and are involved in pathological processes, such as cancer. Among the small ncRNAs, miRNAs are the most explored in tumorigenesis, metastasis development, and resistance to chemotherapy. These small molecules of ~ 22 nucleotides are modulated during early renal development, involved in the regulation of gene expression and Wilms' tumor progression. Wilms' tumors are embryonic tumors with few mutations and complex epigenetic dysregulation. In recent years, the small ncRNAs have been explored as potentially related both in physiological development and in the tumorigenesis of several types of cancer. Besides, genes regulated by miRNAs are related to biological pathways as PI3K, Wnt, TGF-β, and Hippo signaling pathways, among others, which may be involved with the underlying mechanisms of resistance to chemotherapy, and in this way, it has emerged as potential targets for cancer therapies, including for Wilms' tumors.

Keywords: Cell signaling pathways; Gene expression regulation; MicroRNAs; Small non-coding RNAs; Wilms’ tumor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor*
  • Disease Susceptibility
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation, Neoplastic*
  • Genetic Predisposition to Disease
  • Humans
  • MicroRNAs / genetics
  • RNA Interference
  • RNA, Messenger / genetics
  • RNA, Untranslated / genetics*
  • Signal Transduction
  • Wilms Tumor / diagnosis
  • Wilms Tumor / etiology*
  • Wilms Tumor / metabolism
  • Wilms Tumor / therapy

Substances

  • Biomarkers, Tumor
  • MicroRNAs
  • RNA, Messenger
  • RNA, Untranslated